4/A

OWNERSHIP DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: August 25, 2021
Period of Report: August 20, 2021
Accession Number: 0001104659-21-109328

View Document ↗ View on SEC.gov ↗